CAPS, an extremely rare life-long inflammatory disease that interferes with growth and development, causes serious morbidity and is often fatal.
Treatment for Cryopyrin Associated Periodic Disorder comprises two-monthly injections of canakinumab, which is a new profoundly effective but high cost monoclonal antibody therapy.
Below is a list of further information of the service featured on this page. If you require any further information please contact us.